Live Breaking News & Updates on Non Hodgkin Lymphoma
Stay updated with breaking news from Non hodgkin lymphoma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bruton tyrosine kinase (BTK) enzyme inhibitors used to treat B-cell cancers, including chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma, also produce resistance by causing mutations in the protein. Now, a study on the BTK degrader NX-2127 showed the compound could be effective in eliminating BTK regardless of its mutations. ....